Compare BOTJ & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOTJ | DXR |
|---|---|---|
| Founded | 1998 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 61.1M |
| IPO Year | N/A | N/A |
| Metric | BOTJ | DXR |
|---|---|---|
| Price | $18.31 | $13.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | ★ 4.1K | 2.7K |
| Earning Date | 01-30-2026 | 02-27-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | N/A | ★ 3.46 |
| EPS | ★ 1.74 | 0.36 |
| Revenue | ★ $47,669,000.00 | $66,306.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $10.41 | $35.00 |
| Revenue Growth | ★ 8.53 | N/A |
| 52 Week Low | $11.56 | $6.55 |
| 52 Week High | $18.75 | $14.15 |
| Indicator | BOTJ | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 54.33 |
| Support Level | $17.75 | $12.38 |
| Resistance Level | $18.75 | $12.90 |
| Average True Range (ATR) | 0.37 | 0.35 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 26.81 | 74.06 |
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.